TARS icon

Tarsus Pharmaceuticals

44 hedge funds and large institutions have $277M invested in Tarsus Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
10
Reduced
16
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$64.4M
RI
2
RTW Investments
New York
$43.4M
CAM
3
Cormorant Asset Management
Massachusetts
$31.1M -$1.5M -69,438 -5%
FM
4
Frazier Management
Washington
$30.5M
PA
5
Perceptive Advisors
New York
$27.9M
TCM
6
TimesSquare Capital Management
New York
$14M -$774K -35,925 -5%
CAC
7
Cowen and Company
New York
$11.1M
BlackRock
8
BlackRock
New York
$9.52M +$70.4K +3,264 +0.7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$9.25M +$63.5K +2,945 +0.7%
JG
10
Jefferies Group
New York
$9.12M -$431K -20,000 -5%
SCV
11
Sands Capital Ventures
Virginia
$5.6M +$5.6M +260,000 New
Ensign Peak Advisors
12
Ensign Peak Advisors
Utah
$4.31M
GTC
13
Ghost Tree Capital
New York
$3.66M
State Street
14
State Street
Massachusetts
$2.73M +$165K +7,661 +6%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.67M -$39.3K -1,823 -1%
Northern Trust
16
Northern Trust
Illinois
$1.6M -$121K -5,624 -7%
Charles Schwab
17
Charles Schwab
California
$1.01M +$4.16K +193 +0.4%
SG Americas Securities
18
SG Americas Securities
New York
$997K +$502K +23,276 +101%
Invesco
19
Invesco
Georgia
$616K -$39.1K -1,814 -6%
Morgan Stanley
20
Morgan Stanley
New York
$615K +$436K +20,248 +244%
Goldman Sachs
21
Goldman Sachs
New York
$571K -$8.63K -400 -1%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$529K +$63.6K +2,950 +14%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$496K -$90.3K -3,960 -15%
JGC
24
J. Goldman & Co
New York
$478K -$249K -11,553 -34%
Wells Fargo
25
Wells Fargo
California
$210K +$210K +9,784 New